Mapp Biopharmaceutical

A US-based biopharmaceutical company known for developing plant-derived monoclonal antibodies against filoviruses, including ZMapp for Zaire Ebola and MBP134 for pan-Ebola coverage including Bundibugyo.

2 of 2 entries (2 events, 0 interactions)